Track the 진양제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 진양제약 has published 17 public disclosures. Market capitalisation: €49bn. The latest transaction was disclosed on 18 May 2026 (Other). Among the most active insiders: 진양제약. Every trade is free.
17
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
1 ops.
Sell Volume
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,801 of 26,270 companies
73.1
score / 100
Value
73
Quality
73
FCF yld-4.1%
Earn yld41%
EV/EBITDA4.0x
ROE16%
Gross mgn65%
Net mgn18%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.